SMMT Competitors & Alternatives
Compare Summit Therapeutics PLC with similar stocks in the same industry
Biotechnology
SMMT
Main Stock$14.45
Tradestie Score
51
Market Cap
$15.22B
Revenue Growth
-1.0%
Analyst Upside
+96.3%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$205.78
|
$12.36B | 23.9 | 53 | Compare |
|
EXEL
Exelixis Inc
|
$51.62
|
$11.09B | 17.4 | 64 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$28.58
|
$10.76B | - | 55 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$47.71
|
$10.74B | - | 55 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$56.23
|
$10.53B | 40.6 | 61 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$74.08
|
$10.49B | - | 58 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$67.63
|
$10.22B | - | 61 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$471.09
|
$10.01B | - | 51 | Compare |
|
TECH
Bio-Techne Corp.
|
$53.11
|
$9.33B | 76.0 | 55 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$74.66
|
$8.88B | 214.0 | 58 | Compare |
More SMMT Analysis
Data updated: Jun 08, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry